Skip to main content
OpenTrials
Completed

NCT Number: NCT01893021

Family Planning Knowledge, Attitudes, and Practices of Postpartum Malawian Women

The purpose of this study is to understand the family planning needs and practices of postpartum Malawian women, with a focus on long-acting reversible contraception (LARC).

Hypotheses:

1. Postpartum women who are older, who have a history of unintended pregnancy, who do not desire another child within 2 years, and who were counseled about LARC during their pregnancy are more likely to have interest in using LARC. 2. Postpartum women who are older are more likely to be aware of LARC methods. 3. HIV+ postpartum Malawian women will have similar knowledge about LARC as postpartum Malawian women who are HIV-.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contraception

Age range

18 year–45 year

Sex eligibility

Female

Study type

Observational

Primary location

Bwaila Maternity Hospital

Lilongwe, Malawi

About this study

This study is a prospective cohort study of 630 postpartum Malawian women. Since our focus is on HIV+ women, HIV+ participants will be recruited in a 1:2 ratio, with a total of 210 HIV+ women and 420 HIV- women. We will recruit in the postpartum ward of Bwaila Maternity Hospital in Lilongwe, Malawi. Participants will complete a baseline survey about demographics, reproductive health history, and family planning knowledge, attitudes, and practices. At 3, 6, and 12 months postpartum, we will complete follow-up phone calls to determine what family planning methods they are using and if they encountered any barriers to receiving LARC if they had been interested in using them.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Admission to the postpartum ward at Bwaila Maternity Hospital
  • Live birth ≥28 weeks gestational age within past 4 weeks
  • Fluent in English or Chichewa
  • Age 18-45 years
  • Access to a working phone number
  • Willingness to be contacted by phone for up to one year postpartum

Exclusion criteria

  • History of female sterilization via tubal ligation or hysterectomy
  • Prisoner
  • History of mental disability
  • Serious illness that would prevent participation in the opinion of the Principal Investigator

Treatment and study plan

Primary outcomes

  1. Knowledge about the intrauterine device (IUD) and contraceptive implant

    Time frame: Upon enrollment

    A 14-question test about the IUD and implant will be administered to all study participants upon enrollment.

Secondary outcomes

  1. Proportion of women using intrauterine device (IUD) and contraceptive implant

    Time frame: 3, 6, and 12 months postpartum

    We will compare the proportions of HIV+ and HIV- women who are using the IUD and implant at 3, 6, and 12 months postpartum.

  2. Barriers to receiving intrauterine device (IUD) and contraceptive implant

    Time frame: Up to 12 months postpartum

    Descriptive statistics will be used to analyze the reasons given for not receiving the IUD or implant at 3, 5, and 12 months postpartum if a woman had wanted to use it.

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • Fogarty International Center of the National Institute of Health
  • National Institute of Allergy and Infectious Diseases (NIAID)

Registry information

Official study title

Family Planning Knowledge, Attitudes, and Practices of HIV+ and HIV- Postpartum Malawian Women

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jul 8, 2013
Registry last updated
Feb 4, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.